Compared with the Cosmetic Ingredient Review, FDA could consider a wider selection of data in its ingredient safety evaluations under the Personal Care Products Safety Act, an FDA official says. Further, industry would have the burden of demonstrating reasonable certainty of no harm, a high bar to clear.
The Personal Care Products Safety Act would better enable FDA to evaluate cosmetic ingredients and restrict those deemed unsafe, and its assessments would in some cases be more rigorous than those undertaken by the Cosmetic Ingredient Review, according to an agency official.
In an Oct. 5 letter responding to questions from PCPSA sponsor Sen. Dianne Feinstein, D-Calif., FDA’s Acting Associate...
Create an account to read this article
Already a subscriber?
What's going on with the EU Green Claims Directive? HBW Insight speaks to the European Commission, Parliament and Council to find out why trilogue negotiations seem to have stalled.
FDA would receive more funding for fiscal year 2026 in the Senate appropriations bill than its House counterpart, including $10m for unannounced foreign inspections.
The Safer Beauty Bill Package comprises four federal bills introduced in the House that aim to close regulatory ‘gaps’ in cosmetics oversight left by the Modernization of Cosmetics Regulation Act.
The US House of Representatives passes legislation requiring manufacturers of non-flushable wet wipes to label products as ‘non-flushable," a move endorsed by the Personal Care Products Council.
The US House of Representatives passes legislation requiring manufacturers of non-flushable wet wipes to label products as ‘non-flushable," a move endorsed by the Personal Care Products Council.
The European Commission’s Simplification Omnibus published July 8 is ‘step in right direction’ for streamlining processes and providing more legal certainty and predictability for regulations addressing cosmetics, says Cosmetics Europe.
A survey asks FDA staff to disclose whether DEI policies caused discrimination or resulted in disciplinary action against career employees over the past five years, but uses a web form that the general public also can access.
